Aethlon Medical (NASDAQ:AEMD) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Aethlon Medical (NASDAQ:AEMD) in a research note released on Thursday morning,Benzinga reports. HC Wainwright currently has a $7.00 price target on the medical equipment provider’s stock.

Separately, StockNews.com began coverage on Aethlon Medical in a research report on Monday. They issued a “sell” rating for the company.

Aethlon Medical Stock Down 1.5 %

Shares of AEMD opened at $0.73 on Thursday. The company has a 50-day simple moving average of $0.56 and a 200-day simple moving average of $0.45. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $1.88.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.